- Report
- December 2024
- 30 Pages
France
From €4479EUR$4,995USD£3,841GBP
- Report
- December 2024
- 34 Pages
United Kingdom
From €4479EUR$4,995USD£3,841GBP
- Report
- December 2024
- 47 Pages
United States
From €4479EUR$4,995USD£3,841GBP
- Report
- September 2024
- 109 Pages
China
From €1614EUR$1,800USD£1,384GBP
- Report
- September 2024
- 65 Pages
China
From €1614EUR$1,800USD£1,384GBP
- Report
- September 2024
- 220 Pages
China
From €3587EUR$4,000USD£3,076GBP
- Report
- August 2024
- 92 Pages
China
From €1614EUR$1,800USD£1,384GBP
- Report
- August 2024
- 214 Pages
China
From €3587EUR$4,000USD£3,076GBP
- Report
- March 2024
- 132 Pages
Global
From €852EUR$950USD£731GBP
- Report
- March 2024
- 132 Pages
Global
From €852EUR$950USD£731GBP
- Report
- March 2024
- 132 Pages
Global
From €852EUR$950USD£731GBP
- Report
- March 2024
- 132 Pages
Global
From €852EUR$950USD£731GBP
- Report
- June 2023
- 132 Pages
Global
From €852EUR$950USD£731GBP
- Report
- July 2022
- 100 Pages
Global
From €3139EUR$3,500USD£2,691GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more